Insider trade

CEO sold ~$405K of BDX shares in the open market

Traded Jun 1, 2026 · Filed Jun 3, 2026

Becton DickinsonBDX

~$405K
Reported value · 2,764 sh @ $146.35: 110K
Holds after · shares reported: +22.5%
stock since the trade · S&P 500 +0.7%, $145.33 → $178.07 on Oct 1

Why it stands out

The boss of Becton Dickinson sold $405K of Becton Dickinson shares. It happened by itself, for taxes or pay.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jun 1, 2026
Reporting period: Not applicable
Filed with the SEC: Jun 3, 2026

CEO$100K–$500KPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$404,511

Shares × reported transaction price

Timing vs results

25 days after results of May 7, 2026, 66 days before results of Aug 6, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $145.33 on Jun 1, 2026, within 3% of its 52-week low, after an 8% drop over the previous 30 trading days

52-week range $142.35 (May 18, 2026) to $210.02 (Feb 6, 2026), 4% of the way up, from 251 adjusted closes. 30 trading days earlier: $158.54 on Apr 17, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	-1.5%	-2.5%	+1.1%
30 days	+4.0%	-0.8%	+4.8%
90 days	+25.4%	+1.1%	+24.3%

Past results only. Not a forecast.

Source receipt

Record ID: 0001628280-26-040095
Filed / recorded: Jun 3, 2026, 4:44 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: BECTON DICKINSON & CO
Issuer CIK: 10795
Ticker: BDX
Reporting person: Thomas E Jr Polen
Relationship: Director, Officer
Officer title: Chairman, CEO and President
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Jun 1, 2026
Transaction code: S
Shares / units: 2,764
Price per share: $146.35
Acquired / disposed: Disposed (D)
Shares owned after: 110,163
Ownership form: Direct
Amendment: No

Footnotes from the filing

The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $145.21 through $147.49. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.
Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

Around the same time

Officer sold3mo ago

~$11KReported value · 75 sh @ $152.80

Becton Dickinson's Chief Revenue Officer sold $11K of Becton Dickinson shares. Nobody planned it ahead of time.

Why it stands out Official record

Officer sold3mo ago

~$160KReported value · 1,100 sh @ $145.66

Becton Dickinson's & Pres Med.Essntl&BioPharm sold $160K of Becton Dickinson shares. Nobody planned it ahead of time.

Why it stands out Official record

4mo ago

Congress tradeSits on House Energy and Commerce

$1,001 - $15,000Reported range · official band, not an exact amount

3 different filers disclosed BDX within 90 days. Disclosed 28 days after the transaction; reported as an official range, not an exact amount.

Why it stands out Official record